Salt Lake City
United States
ARUP Laboratories
sC5b-9, Terminal Complement Cascade (TCC), Eculizumab, ELISA, Complement-mediated activation, Thrombotic microangiopathy (TMA)
InfliximabAnti-Drug AntibodyImmunogenicityELISAECLIA